Literature DB >> 21953948

Balance measures for propensity score methods: a clinical example on beta-agonist use and the risk of myocardial infarction.

Rolf H H Groenwold1, Frank de Vries, Anthonius de Boer, Wiebe R Pestman, Frans H Rutten, Arno W Hoes, Olaf H Klungel.   

Abstract

PURPOSE: Propensity score (PS) methods aim to control for confounding by balancing confounders between exposed and unexposed subjects with the same PS. PS balance measures have been compared in simulated data but limited in empirical data. Our objective was to compare balance measures in clinical data and assessed the association between long-acting inhalation beta-agonist (LABA) use and myocardial infarction.
METHODS: We estimated the relationship between LABA use and myocardial infarction in a cohort of adults with a diagnosis of asthma or chronic obstructive pulmonary disorder from the Utrecht General Practitioner Research Network database. More than two thousand PS models, including information on the observed confounders age, sex, diabetes, cardiovascular disease and chronic obstructive pulmonary disorder status, were applied. The balance of these confounders was assessed using the standardised difference (SD), Kolmogorov-Smirnov (KS) distance and overlapping coefficient. Correlations between these balance measures were calculated. In addition, simulation studies were performed to assess the correlation between balance measures and bias.
RESULTS: LABA use was not related to myocardial infarction after conditioning on the PS (median heart rate = 1.14, 95%CI = 0.47-2.75). When using the different balance measures for selecting a PS model, similar associations were obtained. In our empirical data, SD and KS distance were highly correlated balance measures (r = 0.92). In simulations, SD, KS distance and overlapping coefficient were similarly correlated to bias (e.g. r = 0.55, r = 0.52 and r = -0.57, respectively, when conditioning on the PS).
CONCLUSIONS: We recommend using the SD or the KS distance to quantify the balance of confounder distributions when applying PS methods.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21953948     DOI: 10.1002/pds.2251

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  9 in total

Review 1.  Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management.

Authors:  Prescott G Woodruff; Alvar Agusti; Nicolas Roche; Dave Singh; Fernando J Martinez
Journal:  Lancet       Date:  2015-05-02       Impact factor: 79.321

2.  Assessing the impact of propensity score estimation and implementation on covariate balance and confounding control within and across important subgroups in comparative effectiveness research.

Authors:  Cynthia J Girman; Mugdha Gokhale; Tzuyung Doug Kou; Kimberly G Brodovicz; Richard Wyss; Til Stürmer
Journal:  Med Care       Date:  2014-03       Impact factor: 2.983

3.  Prognostic score-based balance measures can be a useful diagnostic for propensity score methods in comparative effectiveness research.

Authors:  Elizabeth A Stuart; Brian K Lee; Finbarr P Leacy
Journal:  J Clin Epidemiol       Date:  2013-08       Impact factor: 6.437

4.  Optimizing matching and analysis combinations for estimating causal effects.

Authors:  K Ellicott Colson; Kara E Rudolph; Scott C Zimmerman; Dana E Goin; Elizabeth A Stuart; Mark van der Laan; Jennifer Ahern
Journal:  Sci Rep       Date:  2016-03-16       Impact factor: 4.379

5.  Inhaled bronchodilators and acute myocardial infarction: a nested case-control study.

Authors:  Chang-Hoon Lee; Seongmi Choi; Eun Jin Jang; Han-Mo Yang; Ho Il Yoon; Yun Jung Kim; Jimin Kim; Jae-Joon Yim; Deog Kyeom Kim
Journal:  Sci Rep       Date:  2017-12-20       Impact factor: 4.379

6.  Does co-payment for inhaler devices affect therapy adherence and disease outcomes? A historical, matched cohort study.

Authors:  Jaco Voorham; Bernard Vrijens; Job Fm van Boven; Dermot Ryan; Marc Miravitlles; Lisa M Law; David B Price
Journal:  Pragmat Obs Res       Date:  2017-04-18

7.  An evaluation of exact matching and propensity score methods as applied in a comparative effectiveness study of inhaled corticosteroids in asthma.

Authors:  Anne Burden; Nicolas Roche; Cristiana Miglio; Elizabeth V Hillyer; Dirkje S Postma; Ron Mc Herings; Jetty A Overbeek; Javaria Mona Khalid; Daniela van Eickels; David B Price
Journal:  Pragmat Obs Res       Date:  2017-03-22

8.  Association of Timing of Plasma Transfusion With Adverse Maternal Outcomes in Women With Persistent Postpartum Hemorrhage.

Authors:  Dacia D C A Henriquez; Camila Caram-Deelder; Saskia le Cessie; Joost J Zwart; Jos J M van Roosmalen; Jeroen C J Eikenboom; Cynthia So-Osman; Leo M G van de Watering; Jaap Jan Zwaginga; Ankie W M M Koopman-van Gemert; Kitty W M Bloemenkamp; Johanna G van der Bom
Journal:  JAMA Netw Open       Date:  2019-11-01

9.  Major cardiovascular events in patients with severe COPD with and without asthma: a nationwide cohort study.

Authors:  Barbara Bonnesen; Pradeesh Sivapalan; Anna Kjær Kristensen; Mats Christian Højbjerg Lassen; Kristoffer Grundtvig Skaarup; Ema Rastoder; Rikke Sørensen; Josefin Eklöf; Tor Biering-Sørensen; Jens-Ulrik Stæhr Jensen
Journal:  ERJ Open Res       Date:  2022-09-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.